0001567619-20-011002.txt : 20200522 0001567619-20-011002.hdr.sgml : 20200522 20200522161551 ACCESSION NUMBER: 0001567619-20-011002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200520 FILED AS OF DATE: 20200522 DATE AS OF CHANGE: 20200522 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HULME GEOFFREY CENTRAL INDEX KEY: 0001307047 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30319 FILM NUMBER: 20906061 MAIL ADDRESS: STREET 1: C/O PORTER ORLIN LLC STREET 2: 666 FIFTH AVENUE, 34TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Innoviva, Inc. CENTRAL INDEX KEY: 0001080014 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943265960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 SIERRA POINT PARKWAY STREET 2: SUITE 500 CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: 6502389600 MAIL ADDRESS: STREET 1: 2000 SIERRA POINT PARKWAY STREET 2: SUITE 500 CITY: BRISBANE STATE: CA ZIP: 94005 FORMER COMPANY: FORMER CONFORMED NAME: THERAVANCE INC DATE OF NAME CHANGE: 20020207 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MEDICINE INC DATE OF NAME CHANGE: 20000302 4 1 doc1.xml FORM 4 X0306 4 2020-05-20 1 0001080014 Innoviva, Inc. INVA 0001307047 HULME GEOFFREY 1350 OLD BAYSHORE HIGHWAY, SUITE 400 BURLINGAME CA 94010 0 1 0 0 Interim Principal Exec Officer Common Stock 2020-05-20 4 F 0 339 14.10 D 46251 D Common Stock 3500 I See Footnote The shares were withheld by the Issuer to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity grants. Includes 1,121 shares of common stock acquired under the Innoviva, Inc. Employee Stock Purchase Plan (ESPP) on May 15, 2020. The reportable securities are owned directly by Steel Valley Capital LLC. The Reporting Person is the owner and manager of Steel Valley Capital LLC. /s/ Geoffrey Hulme 2020-05-21